🇺🇸

US SEC Filing Intelligence

· daily

US Merger & Acquisition SEC Filings — June 09, 2026

The US M&A landscape on June 9, 2026, is dominated by SPAC activity, with 10 of 14 filings involving blank-check companies at various stages of their lifecycle. A clear bifurcation is emerging: high-quality SPACs with attractive targets (QuasarEdge/Robseek, Live Oak/Teamshares) are progressing toward completion, while others face existential risks from delisting (Eureka Acquisition) and governance failures (Renatus Tactical). The most critical development is Getaround's confirmed dissolution, representing a total loss for equity holders and highlighting the risks in distressed SPAC survivors. Period-over-period comparisons reveal no revenue or margin data across filings, but insider activity and capital allocation signals are stark: Getaround's liquidation and Renatus's board resignation are bearish, while Live Oak's non-redemption agreements and Flag Ship's compliance regain are bullish. The SPAC sector is showing signs of maturity, with deal values ranging from $1 billion (QuasarEdge/Robseek) to undisclosed amounts, and extension deadlines creating time-sensitive catalysts. Investors should focus on the June 16 Live Oak shareholder vote and the June 15 Ribbon Acquisition deadline as near-term events.

14 high priority 14 total filings
· monthly

US Pre-Market SEC Filings Roundup — June 09, 2026

The 50 filings reveal a mixed landscape with notable M&A activity, SPAC developments, and mixed earnings results. Key themes include significant acquisitions in healthcare (GSK/Nuvalent $10.6B, Novanta/Riverpoint $1.45B), SPAC business combinations progressing (Inflection Point/Air Water, IQM/Real Asset), and mixed consumer results with Designer Brands and Lands' End showing revenue declines but margin improvements. Period-over-period trends highlight margin compression in food companies (Nathan's Famous beef costs up 19%) and technology (AITX revenue up 26% but still loss-making). Insider activity is limited, but capital allocation shows debt offerings (Cipher Mining $810M) and buybacks (News Corp $1B program). Forward-looking guidance is cautious (Smucker's FY27 sales decline 3-4%) but with some positive EPS growth expectations. The most critical development is

27 high priority 23 medium 50 total filings
· daily

S&P 500 Technology Sector SEC Filings — June 08, 2026

The 18 filings for the S&P 500 Technology stream reveal a pronounced focus on corporate control events, with the Genco Shipping proxy fight and tender offer dominating the news flow, creating a high-stakes binary outcome for shareholders. While the AvalonBay/Equity Residential merger-of-equals progresses with a named leadership team and compensation packages, the lack of financial data in these filings limits quantitative trend analysis. A new SPAC IPO (AParadise II) signals continued appetite for blank-check vehicles, while a biotech resale registration (AIM ImmunoTech) highlights dilution risk. The overall sentiment is neutral-to-mixed, with no clear sector-wide growth or margin trends emerging from the period-over-period data, as most filings are event-driven rather than performance-based. The most actionable intelligence centers on the Genco proxy contest and the AvalonBay merger integration, with the former offering a near-term catalyst and the latter a long-term value creation story. Insider activity is minimal, with only board-level changes at Shenandoah Telecom and a resignation at Invesco CurrencyShares, providing no clear management conviction signals. Capital allocation is addressed only in the context of Genco's dividend policy and the AvalonBay merger compensation, with no buyback or dividend change data available. The primary themes are M&A integration, activist pressure, and capital formation via SPACs, with a notable absence of operational or financial performance data across the filings.

9 high priority 9 medium 18 total filings
· daily

Nasdaq 100 Stocks SEC Filings — June 08, 2026

The 22 filings for the NASDAQ-100 stream on June 8, 2026, reveal a market dominated by corporate control events, M&A integration, and early-stage biotech catalysts. The most significant cluster of activity surrounds Genco Shipping & Trading (GNK), which faces an escalating proxy fight and unsolicited tender offer from its largest shareholder, Diana Shipping, creating a high-stakes binary event ahead of its June 18 annual meeting. Concurrently, the AvalonBay (AVB) and Equity Residential (EQR) merger-of-equals is progressing through integration milestones, with the combined entity set to manage over 180,000 apartment homes, though no financial terms were disclosed. In the biotech space, MetaVia (MTVA) reported promising early-stage obesity data (9.1% weight reduction at Day 54) and secured shareholder approval for a reverse stock split, while AIM ImmunoTech filed for a significant share resale, highlighting the capital-intensive nature of development-stage companies. A new SPAC, AParadise II Acquisition Corp., entered the market with a $135M IPO, signaling continued appetite for blank-check vehicles. Notably, the filings lack broad period-over-period financial comparisons or insider trading activity, limiting trend analysis but sharpening the focus on specific corporate events and regulatory milestones.

11 high priority 11 medium 22 total filings
· daily

S&P 500 Financials Sector SEC Filings — June 08, 2026

The 50 filings from S&P 500 Financials and related sectors reveal a bifurcated landscape: a handful of companies are executing aggressive restructurings and turnarounds (e.g., Aeries Technology swinging from a -$21.6M loss to +$3.5M net income, Noble Romans flipping to profitability), while others face existential distress (Silver Star Properties REIT, GoHealth filing for Chapter 11). A dominant theme is the use of capital markets for balance sheet repair and growth financing, with Ares Capital launching a $1B CP program, Ciena pricing a $2B convertible note, and Strive authorizing up to $5.15B in at-the-market offerings. Insider activity is sparse but notable, with no major insider buying or selling detected across the filings. Forward-looking data points to a rich catalyst calendar, including a major Roche collaboration for Nurix ($700M upfront), a transformative reverse merger for SUNation Energy (98.2% dilution for current holders), and a potential hostile takeover battle for Genco Shipping. Period-over-period comparisons show margin expansion is a key driver of earnings improvement, with Duluth Holdings expanding gross margins by 540 bps and Aeries Technology slashing SG&A by 72%. The most critical development is the wave of M&A and strategic pivots, which creates both significant upside potential and substantial downside risk for shareholders.

25 high priority 25 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — June 08, 2026

The 50 filings in the S&P 500 Consumer Staples stream reveal a sector under significant pressure from cost inflation, tariffs, and shifting consumer behavior, with several major players reporting declining sales and compressed margins. Campbell's Q3 FY2026 sales fell 4% YoY with adjusted EBIT down 24%, while Kraft Heinz is proactively reducing debt by redeeming $1 billion in notes. Constellation Brands is navigating a leadership transition amid a subdued beer category, though its Beer Division continues to outperform. Outside the core staples, the filings show a flurry of capital market activity, including a $1.9 billion debt offering by Hubbell for an acquisition and a $400 million convertible note offering by Celcuity. A notable governance theme is shareholder dissent, with ARKO Corp. seeing a 24.8% withhold vote for one director and Gabelli Dividend & Income Trust facing an activist challenge from Saba Capital. The overall sentiment is mixed, with a few bright spots like Motorcar Parts of America's strong Q4 turnaround and Vivakor's new $108 million annualized crude oil contract, but the prevailing trend is one of cautious management and strategic repositioning.

21 high priority 29 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — June 08, 2026

The 50 filings for the S&P 500 Industrials stream reveal a sector in flux, with a pronounced divergence between industrial heavyweights executing strategic mergers (AvalonBay/Equity Residential) and smaller, capital-intensive companies facing liquidity and governance pressures. A dominant theme is the aggressive activist campaign by Diana Shipping against Genco Shipping & Trading, which has generated a flurry of 6+ filings and highlights deep sectoral tensions in dry bulk shipping. While some companies like U.S. Global Investors show a strong operational turnaround (net income swing of +$3.1M YoY), others like ChargePoint are burning cash despite improving gross margins, with equity turning negative. The period-over-period data is sparse across the 50 filings, but the available comparisons point to a 'two-speed' industrials market: large-cap REITs and defense-adjacent firms are consolidating for scale, while smaller caps in EV infrastructure, biotech, and shipping are fighting for survival via debt restructuring, reverse splits, and proxy battles. Capital allocation is mixed, with preferred dividends being maintained (Babcock & Wilcox) but cash positions deteriorating at several firms. The most critical development is the AvalonBay/EQR merger-of-equals, which will create a 180,000+ unit apartment behemoth, signaling a bet on multi-family housing demand. Overall, the stream suggests a market where scale and balance sheet strength are paramount, and where activist investors are sensing opportunity in undervalued or mismanaged assets.

24 high priority 26 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — June 08, 2026

Today's filings from the S&P 500 Energy sector reveal a market bifurcated between capital-raising vehicles and operational companies adjusting to new realities. EShallGo Inc. (EHGO) is pursuing an IPO with a complex structure and a recent capital reduction at a key subsidiary, signaling potential governance complexity. AParadise II Acquisition Corp. is launching a $135M SPAC IPO, reflecting continued appetite for blank-check vehicles despite a challenging regulatory environment. Knightscope, Inc. has restructured executive compensation with aggressive market-cap-based performance targets, aligning management with shareholder value creation but also signaling a high-risk, high-reward strategy. Across the three filings, there is no direct period-over-period financial data available, but the capital allocation patterns (IPO, SPAC, performance-based compensation) suggest a sector focused on raising and incentivizing capital for growth rather than returning it to shareholders. The absence of insider trading activity in these filings is notable, though the lock-up agreements in the IPO filings will constrain insider sales. The key takeaway is a sector in transition, with companies using different financial engineering tools to navigate the current energy landscape.

3 high priority 3 total filings
· daily

US Material Events SEC 8-K Filings — June 08, 2026

The June 8, 2026, filing batch reveals a market bifurcated between aggressive capital markets activity and significant corporate distress. A wave of debt and equity financing dominates, with $3.3 billion in new debt offerings from ATI, Hubbell, and FS KKR Capital Corp, alongside a $400 million convertible note from Celcuity, signaling robust credit appetite for investment-grade and BDC names. However, this is counterbalanced by three high-profile bankruptcies (GoHealth, Silver Star Properties, and a reverse merger from SUNation Energy), indicating severe stress in healthcare, real estate, and solar manufacturing. Governance upheaval is a key theme, with a CEO fired for misconduct at Perrigo, three directors removed at Pangaea Logistics, and a wave of director/officer resignations across multiple Invesco ETFs. The most transformative event is Nurix Therapeutics' $700 million upfront collaboration with Roche, a landmark biotech deal that dwarfs all other transactions in this batch. Insider activity is notably absent, but the lack of insider buying alongside the equity offerings suggests cautious management sentiment. The data points to a 'haves vs. have-nots' environment where well-capitalized firms are raising cheap debt for M&A, while over-levered entities are forced into restructuring.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — June 08, 2026

The 50 filings from Dow 30 constituents on June 8, 2026, reveal a market bifurcated between operational discipline and aggressive financial engineering. While several companies like Duluth Holdings and AstroNova show clear operational turnarounds with margin expansion and improved profitability, a significant cluster of filings signals heightened risk through increased leverage, dilutive capital raises, and insider departures. Notably, the SPAC market is active with two new IPOs and a business combination, indicating continued appetite for blank-check vehicles. Key themes include a focus on cost optimization, strategic pivots (e.g., Volato to AI), and shareholder activism in M&A (Two Harbors). The most critical development is the Silver Star Properties REIT bankruptcy, a stark reminder of credit risk in the real estate sector. Overall, the data suggests a cautious but opportunistic market environment where investors should favor companies with demonstrable operational improvements and scrutinize those relying on financial maneuvers.

32 high priority 18 medium 50 total filings
· daily

US SEC Filings Daily Market Digest — June 08, 2026

Today's filings reveal a market bifurcated between aggressive restructuring and strategic growth. The most critical developments are two high-profile bankruptcies (GoHealth and Silver Star Properties REIT) signaling distress in healthcare and real estate, contrasted with a landmark $700M upfront biotech collaboration (Nurix Therapeutics) and a transformative defense AI partnership (Palladyne AI). Period-over-period data shows a mixed earnings picture: Noble Romans swung to profitability (+$1.2M net income vs -$3K loss), while Duluth Holdings narrowed losses but saw sales decline 4% YoY. Capital allocation trends are divergent, with Ares Capital launching a $1B CP program for cheaper funding and Ciena announcing a $2B convertible note offering paired with a $140M buyback. Insider activity is limited, but the failed say-on-pay vote at nLIGHT (61% against) signals potential governance friction. The overarching theme is a 'survival of the fittest' environment where companies with strong balance sheets and strategic clarity (Nurix, Palladyne, Ciena) are positioning for growth, while overleveraged entities face existential restructuring.

25 high priority 25 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — June 08, 2026

The 50 filings reveal a mixed landscape in the S&P 500 Consumer Discretionary sector, with notable divergence between strong performers and those facing headwinds. Revenue growth trends are uneven: Motorcar Parts of America (MPAA) posted 9.9% YoY Q4 growth and a swing to profitability, while FuelCell Energy saw a 4.8% revenue decline and a widened net loss. Margin compression is a recurring theme, with Oil-Dri Corp's gross margin falling 190 bps to 26.7% despite 9% revenue growth. Insider activity is sparse but includes significant capital allocation moves: FICO authorized a $2.0B buyback and $1.5B ASR, signaling strong shareholder returns. Forward-looking data shows MPAA guiding FY2027 sales of $780M-$800M (7.5%-10.2% growth) and FuelCell Energy expanding capacity to 500 MW. Restatements at FDCTech (10 filings) raise governance red flags, while SPAC activity (Inflection Point/Quantum Space) adds speculative risk. Overall, the sector shows selective strength in auto parts and restaurant chains, but consumer-facing companies face margin pressure and rising input costs.

22 high priority 28 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — June 08, 2026

The 25 filings in the S&P 500 Healthcare stream reveal a mixed picture with some pockets of strength and notable red flags. While several companies are aggressively returning capital to shareholders through buybacks and dividends, others are facing severe operational headwinds. The most critical development is the sharp deterioration at New Century Logistics (BVI) Ltd, which swung from a profit to a $10.73M net loss, driven by a collapse in gross profit and a surge in stock-based compensation. Emerging trends include significant insider activity, with a handful of companies signaling management conviction through leadership appointments and governance enhancements, while other firms show potential dilution risk and shareholder dissent on compensation. The sector is also seeing increased M&A activity and capital raises, particularly in the SPAC and crypto-adjacent spaces, which carry elevated risk. Overall, the data suggests a bifurcated market where disciplined capital allocators and growing firms are being rewarded, while companies with deteriorating fundamentals face increasing scrutiny.

11 high priority 14 medium 25 total filings
· daily

US Executive Compensation Proxy SEC Filings — June 08, 2026

This batch of 11 proxy filings reveals a market dominated by capital structure engineering and survival financing, with governance concerns concentrated in heavy-handed insider control. Several micro-cap biotechnology firms (BiomX, Tempest, Achieve Life Sciences) and distressed entities (Purple Innovation, Vivakor) are seeking massive share issuances or reverse splits, signaling acute cash burn and reliance on equity-linked funding. A notable governance overhang exists at Bit Digital, where 2% economic ownership controls 14% voting power via super-voting shares—a structure that should concern minority investors. Conversely, larger-cap names like Constellation Brands and Jazz Pharmaceuticals show institutional stability, with orderly leadership transitions and standard compensation proposals. The data reveals a binary risk profile: the six 'new' filings carry existential capital-raising risks, while the five carryover filings represent steady-state governance. Insider trading data is notably absent in most filings (zero material transactions flagged), limiting conviction signals on management sentiment. Forward-looking catalysts cluster in late June (BiomX/Tempest special meetings, Vivakor AGM) and late July (Constellation, Jazz, AmeriServ AGMs). The most actionable insight is the overwhelming number of reverse-split proposals—3 out of 11 filings—signaling sector-wide distress that investors can use as a bearish signal for micro-cap exposure.

11 high priority 11 total filings
· daily

US IPO Pipeline SEC S-1 Filings — June 08, 2026

The IPO pipeline on June 8, 2026, is dominated by three new SPAC filings (AParadise II, Research Alliance Corp IV, and Cartesian Growth Corp IV) collectively seeking to raise $635 million, signaling a resurgence in blank-check activity despite a challenging regulatory environment. Among the three follow-on filings, AIM ImmunoTech, HCW Biologics, and Agape ATP Corp all exhibit mixed sentiment due to operational risks, Nasdaq compliance issues, and uncertain capital structures. Period-over-period data reveals Agape ATP Corp narrowing its net loss by 52% YoY in Q1 2026, while AIM ImmunoTech and HCW Biologics show no revenue from approved products, relying on warrant exercises for potential cash. Insider activity is absent across all filings, but forward-looking statements highlight key catalysts: AIM's planned Phase 3 pancreatic cancer trial with Thermo Fisher, HCW's Phase 1 alopecia areata data, and Agape's unresolved $24.1M investment deposit. The most critical developments are the SPACs' lack of identified targets, which creates binary risk, and the biotech firms' reliance on regulatory approvals and Nasdaq compliance deadlines. Portfolio-level patterns include a concentration of high-risk, pre-revenue companies in the follow-on space and a return of large SPAC IPOs targeting $250M+ raises.

6 high priority 6 total filings
· daily

Global High-Priority Regulatory Events — June 08, 2026

The June 8, 2026, filing stream reveals a market bifurcated between aggressive capital restructuring and fundamental operational stress. The most critical event is the Chapter 11 filing by Silver Star Properties REIT (Materiality 10/10), signaling severe distress in commercial real estate, while GoHealth's prepackaged Chapter 11 (Materiality 9/10) highlights a strategic debt restructuring that will wipe out common equity. A wave of reverse mergers and SPAC deals is reshaping the small-cap landscape, with SUNation Energy's acquisition of Suniva (Materiality 9/10) creating a dominant U.S. solar cell manufacturer but diluting existing SUNE shareholders by 98.2%. On the positive side, Nurix Therapeutics' $700M upfront Roche collaboration (Materiality 9/10) and Bending Spoons' 237% revenue growth over two years (Materiality 9/10) represent standout opportunities in biotech and tech, respectively. Period-over-period trends show a mixed picture: Aeries Technology swung to profitability but on flat revenue, while FuelCell Energy's losses widened 103% YoY due to a $42.6M impairment. Portfolio-level patterns indicate a surge in debt financing (MSD Investment Corp tripling its unsecured debt limit to $600M, Ares Capital's $1B CP program) and a concerning number of insolvency/restructuring filings (Future Lifestyle, PS IT, Future Consumer, Silver Star, GoHealth). Insider activity is notably absent from most filings, but the board removals at Pangaea Logistics and the mass resignation of Jordan Krugman from five Invesco entities signal governance instability.

50 high priority 50 total filings
· daily

US Earnings Financial Results SEC Filings — June 08, 2026

The 21 filings reveal a deeply bifurcated earnings landscape. While top-line growth is present in several names (GRAHAM CORP +17%, Elastic N.V. +17%, Mama's Creations +49.7%), it is often masking underlying margin compression or one-time benefits. A significant cluster of companies is reporting widening net losses or sharp profit declines, driven by impairment charges (FuelCell Energy, Columbus McKinnon), transaction costs (Mission Produce), and rising R&D (Seaport Therapeutics). The most critical development is the prevalence of 'mixed' sentiment (12 of 21 filings), indicating that even companies with revenue growth face headwinds from cost inflation, cash burn, or balance sheet deterioration. Portfolio-level patterns show a clear divide: capital-intensive and industrial names are struggling with debt and impairments, while select consumer and tech firms are demonstrating genuine operational leverage. Insider activity is notably absent from the enriched data, but forward-looking guidance from GRAHAM CORP (+16-20% revenue growth) provides a key catalyst to watch.

21 high priority 21 total filings
· daily

US SEC Trading Suspension Halt Orders — June 08, 2026

The single filing in this intelligence stream, from aTyr Pharma, highlights a critical delisting risk due to non-compliance with Nasdaq's minimum bid price rule. The company has received a second 180-day compliance period, extending the deadline to November 30, 2026, but there is no assurance of success. The negative sentiment and high materiality score (8/10) underscore the severity of the situation for shareholders. No period-over-period comparisons, insider activity, or forward-looking guidance were available in the enriched data, limiting the depth of trend analysis. The key development is the company's failure to meet the initial deadline and its reliance on a second grace period, which introduces significant uncertainty. The market implication is a heightened risk of a sudden trading suspension and potential delisting, which would severely impact liquidity and valuation.

1 high priority 1 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — June 08, 2026

This intelligence stream reveals a bifurcated corporate landscape: a wave of distressed companies is resorting to dilutive financing, reverse mergers, and Chapter 11 filings to survive, while a separate cohort of fundamentally sound firms is aggressively accessing capital markets for growth and acquisitions. The most critical developments include three bankruptcy filings (GoHealth, Silver Star Properties, and a prepackaged restructuring) and multiple going-concern warnings signaled by dilutive offerings and debt restructurings. Key period-over-period trends from the data show a stark contrast: Village Farms' revenue grew 15% YoY while Cerus increased its debt load by $5M, and FICO's $2B buyback signals confidence versus Volato's speculative pivot. A portfolio-level pattern emerges in the energy and solar sectors, where SUNation's reverse merger and Vivakor's $108M annualized crude oil deal highlight a push for scale and revenue diversification. The most actionable intelligence lies in tracking the 5 companies with imminent bankruptcy risks and the 3 companies with significant capital allocation events that could drive shareholder value.

48 high priority 48 total filings
· daily

US Executive Officer Management Changes SEC — June 08, 2026

This intelligence stream covering 50 filings from June 8, 2026, reveals a surge in executive leadership changes across sectors, with a notable bias toward CFO appointments and unexpected departures. Key themes include orderly succession planning in large caps (Lennar, Farmer Mac, First Watch) contrasted with abrupt exits driven by personal conduct (Perrigo CEO) and governance overhauls (Pangaea Logistics removed three directors). Insider activity is sparse, but capital allocation signals are mixed—Knightscope's aggressive incentive plan ($65M market cap awards) contrasts with the risk of dilution at Savara (601M authorized shares). Forward-looking data reveals a muted growth outlook: Perrigo reaffirmed net sales decline of up to 5.5%, while Clarivate reaffirmed 2026 guidance. Sector-wise, real estate (Equity Residential/AvalonBay merger) and biotech (Ionis board refresh) show consolidation for scale. Period-over-period comparisons are limited in these filings, but equity plan approvals with notable opposition (MetaVia 13.0% against reverse split, Avalo Therapeutics ESPP with 6.6M against) signal shareholder vigilance. The intelligence suggests portfolio focus on companies with stable transitions and tangible performance metrics, while flagging governance risk and dilution events.

50 high priority 50 total filings